"I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into one average sales price calculation and payment code."
"The Chair thanks the gentlelady. That concludes the questions that we have here. We have follow-up questions. We will submit those to you in writing. We ask that you please respond promptly."
"I urge my colleagues to support both of these amendments and the underlying resolution."
"opening statement"
"The chair thanks the gentleman."
"In order to advance each of them, we must establish a regulatory environment that fosters the development of, and access to, innovative, accurate, and reliable diagnostic testing."
"I am eager to hear what Dr. Conway has to say on the matter."
"In my mind that would not include issuing guidances, fiats that are expected to be followed, but rather, you go through the normal administrative procedures."
"This bill would authorize the appropriations of $16 million for HHS to identify and publish quality measures for maternal and infant health."
"Today's hearing will review the accuracy of eligibility and financing determinations made by the Center of Medicare and Medicaid Services, CMS."
"As we have heard from our senior constituents, they rely on the Part D program and Congress has a responsibility to ensure that the MTM program is working as intended."
"Prescription drug abuse does not discriminate: it is not limited by geography, income, or age."